Company profile
Ticker
BIOVF, SWOBY
Exchange
Employees
Incorporated
Fiscal year end
SEC CIK
Latest filings (excl ownership)
Latest ownership filings
No filings
Press releases
European Commission grants Sobi® Marketing Authorisation for ALTUVOCT™ for treatment of haemophilia A
19 Jun 24
Bulletin from Sobi's Annual General Meeting (AGM)
14 May 24
Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A
26 Apr 24